Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNT162b2 variant-adapted vaccine in healthy adults
NCT07730450Phase 4Recruiting
- Sponsor
- BioNTech SE
- Start
- Jul 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 4 trial of tozinameran in coronavirus disease 2019 (COVID-19), sponsored by BioNTech SE. Started Jul 2026; status: recruiting.
02
Drugs
tozinameran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07730450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07730450.